Assignment of the Fidaxomicin Japan technology licensing agreement to Zeria Pharmaceutical Co., Ltd.
An individual transaction involving the transfer to Zeria Pharmaceutical Co., Ltd. of the technology licensing agreement with Merck for fidaxomicin in Japan, including an option to continue sales after the transfer.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.